OpenAlex
PricingAboutJobs
Log inGet started
Work

Optimal Dosing for Targeted Therapies in Oncology: Drug Development Cases Leading by Example

HTML

Year: 2015
Type: review
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-15-1295
Authors: Jeffrey R. Sachs, Kapil Mayawala, Satvik Gadamsetty, Soonmo Peter Kang, Dinesh P. de Alwis
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English

Topic: Statistical Methods in Clinical Trials
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Keywords: targeted therapy, dose selection, dose-limiting toxicity, maximum tolerated dose, dose-ranging, pharmacodynamic biomarkers, target engagement, monoclonal antibodies, immunotherapy, anticancer drug development, hematologic malignancies, solid tumors
SDG: Good health and well-being

Open Access status: closed

Funders: University of Texas MD Anderson Cancer Center, National Cancer Institute
OpenAlex ID: W2173235643
FWCI: 1.924
Cites: 33
Cited by: 165
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security